|
Match
|
Document |
Document Title |
|
|
5496846 |
Taxol treatment of breast cancer
The present invention is a method of treatment for a patient with cancer. In particular, it is a method of treating patients having breast cancer using the microtubule agent, Taxol. The present...
|
|
|
5489601 |
Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
Taxane derivatives having a 3' pyridyl substituted C13 side chain.
|
|
|
5489589 |
Amino acid derivatives of paclitaxel
The present invention concerns water-soluble amino acid derivatives of paclitaxel, their use as antitumor agents, and pharmaceutical compositions containg the compounds.
|
|
|
5484809 |
Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid
The oral delivery of many classes of drugs is facilitated by converting drugs having suitable functional groups to 1-O-alkyl-, 1-O-acyl-, 1-S-acyl, and 1-S-alkyl-sn-glycero-3-phosphate derivatives....
|
|
|
5480639 |
Methods for isolating individual taxanes
Methods of obtaining renewable sources of taxanes including taxol are provided. Compositions comprising taxanes which are useful as source materials for the further purification of taxanes are also...
|
|
|
5478860 |
Stable microemulsions for hydrophobic compound delivery
Microemulsion compositions for the delivery of hydrophobic compounds are provided. Such compositions have a variety of uses. In one embodiment, the hydrophobic compounds are therapeutic agents...
|
|
|
5478854 |
Deoxy taxols
Further provided by this invention are pharmaceutical formulations and intermediates for the the preparation of deoxy taxols of formula I. A method of treating mammalian tumors using a compound of...
|
|
|
5474774 |
Adhesion inhibiting composition
An extract prepared from plants of the genus Vaccinium, especially cranberries, which is enriched for an activity which inhibits bacterial adhesion to surfaces. The extract is also enriched for...
|
|
|
5470866 |
Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol
The natural product cephalomannine can be converted to the important anticancer natural product taxol by a simple process involving the steps of dihydroxylation to give cephalomannine-diols, diol...
|
|
|
5468769 |
Paclitaxel derivatives
A compound or prodrug thereof having the formula ##STR1## wherein --OR 1 comprises the C-13 side-chain of taxol and Z is selected from the group consisting of --CHO, --CH 2 OH, --CH 2 OR', --CH...
|
|
|
5466708 |
Oxetanones
Novel compounds of the formula ##STR1## wherein Q, R 1 and R 2 are described herein, are disclosed along with pharmaceutical compositions, methods of use, and process for producing compounds of...
|
|
|
5447953 |
Biomasses to treat non-human animals
The use of biomasses obtained in the fermentative production of lipase inhibitors, especially lipstatin, for the preparation of foodstuffs, feedstuffs, food additives, feed additives, feed...
|
|
|
5438072 |
Taxoid-based compositions
The present invention relates to new taxoid-based compositions consisting of solutions of these derivatives in a surface-active agent. These solutions are used for preparing perfusion solutions.
|
|
|
5426109 |
Phenylnaphthalene hydroxy acids
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They...
|
|
|
5426111 |
[Alkoxy-, alkenyloxy-, alkynyloxy-, and phenylmethyloxyalkoxycycloalkyl or alkoxycycloheteroalkyl]naphtho[2,3-c]furan-1(3H)-one inhibitors of 5-lipoxygenase
Compounds of formula ##STR1## Ar is selected from (a) phenyl, (b) phenyl substituted with one or more groups selected from halogen, cyano, alkyl, haloalkyl, alkoxy, and alkoxycarbonyl, (c) furyl,...
|
|
|
5411984 |
Water soluble analogs and prodrugs of taxol
Substituted 2'-benzoyl and 2', 7-dibenzoyl taxol derivatives are synthesized which have improved water solubility and stability while maintaining bioactivity. In a preferred embodiment, taxol...
|
|
|
5407683 |
Pharmaceutical solutions and emulsions containing taxol
Compositions of matter are provided comprising a pharmaceutically effective amount of taxol or a tumor-active analog thereof solubilized in a pharmaceutically acceptable carrier comprising an oil...
|
|
|
5407674 |
Taxane having antitumor activity
The present invention relates to a new taxane having the structure (1), which is isolatable from root bark of plants of the Taxus genus. The compound (1) is endowed with antitumor activity higher...
|
|
|
5403858 |
New compositions containing taxane derivatives
Compositions containing taxane derivatives, consist of a solution of such derivative in a surfactant consisting of polysorbate, polyethelene glycol or hydrogenated castor oil. These compositions...
|
|
|
5362731 |
Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders
Piribedil is administered to patients to treat unstable or hyperactive bladders.
|
|
|
5358711 |
Stimulation of stem cell growth by the bryostatins
In vivo and in vitro methods are taught for stimulating the differentiation of stem cells using certain bryostatins. Stem cells can be induced to form granulocytes, macrophages and erythrocytes. In...
|
|
|
5356928 |
Cytotoxic agents
The invention relates to pharmaceutical compositions comprising an effective cytotoxic amount of: ##STR1## Wherein R represents Ac or H; R' represents: ##STR2## OH; and R" represents: ##STR3##...
|
|
|
5356927 |
Methods of treating plasmodium and babesia parasitic infections
Methods of inhibiting the proliferation of Plasmodium or Babesia parasites are provided by the present invention. Such methods may be useful for treating malaria and babesiosis in mammals such as...
|
|
|
5348979 |
Method of promoting nitrogen retention in humans
Nitrogen retention in human subjects is promoted by administering β-hydroxy-β-methylbutyric acid (HMB). The amount of HMB administered is effective to conserve protein as determined by reduction...
|
|
|
5336684 |
Oxidation products of cephalomannine
Antineoplastic taxol derivatives are derived by selective oxidation of the alkene portion of the side chain of cephalomannine. The derivative displays high activity in promoting assembly of...
|
|
|
5314891 |
Benzenesulphonamide derivatives
The invention concerns benzenesulphonamide derivatives of the formula I ##STR1## wherein R 1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; R 2 and R 3 together form --A 2 --X 2 --A 3 --...
|
|
|
5296506 |
Rearranged taxol compounds and method of using in testing of in vivo activity
In a preferred embodiment, taxol is treated with mesyl chloride to prepare a taxol derivative with a contracted A-ring, which has comparable activity to taxol in a tubulin depolymerization assay,...
|
|
|
5294637 |
Fluoro taxols
This invention relates to a fluorinated taxol of formula I ##STR1## in which R 1 is --COR z in which R z is RO-- or R; R g is C 1 -6 alkyl, C 2 -6 alkenyl, C 2 -6 alkynyl, C 3 -6 cycloalkyl,...
|
|
|
5284865 |
Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
Taxane derivatives of the formula ##STR1## wherein R 1 is cyclohexyl, R 3 is phenyl, T 1 is hydrogen, hydroxyl protecting group, or --COT 2 , T 2 is H, C 1 -C 6 alkyl, C 2 -C 6 ...
|
|
|
5284864 |
Butenyl substituted taxanes and pharmaceutical compositions containing them
Taxane derivatives of the formula ##STR1## wherein R 1 is butenyl, R 3 is phenyl, T 1 is hydrogen, hydroxyl protecting group, or --COT 2 , T 2 is H, C 1 -C 6 alkyl, C 2 -C 6 ...
|
|
|
5283253 |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
Taxane derivatives of the formula ##STR1## wherein R 1 is phenyl or p-nitrophenyl, R 3 is furyl or thienyl, T 1 is hydrogen, hydroxyl protecting group, or --COT 2 , T 2 is H, C 1 -C 6...
|
|
|
5272171 |
Phosphonooxy and carbonate derivatives of taxol
The present invention is directed to novel taxol derivatives useful as anti-tumor agents. Also provided by this invention is pharmaceutical formulations and methods of treating mammalian tumors...
|
|
|
5262409 |
Binary tumor therapy
Method for killing a cycling cell, by contacting the cell with a first agent that blocks progression of the cell cycle in the cell, and thereafter contacting the cell with a second agent that...
|
|
|
5260310 |
Oxetanone compounds and pharmaceutical compositions containing them
Novel compounds of the formula ##STR1## wherein Q, R 1 and R 2 are described herein, are disclosed along with pharmaceutical compositions, methods of use, and process for producing compounds of...
|
|
|
5254580 |
7,8-cyclopropataxanes
An antitumor compound of formula I ##STR1## in which R 1 is --COR z in which R z is t-butyloxy, C 1 -6 alkyl, C 2 -6 alkenyl, C 2 -6 alkynyl, C 3 -6 cycloalkyl, or phenyl, optionally substituted...
|
|
|
5246960 |
Oxetanones
Racemic compounds of the formula ##STR1## wherein R 1 , R 2 , R 3 , R 4 , R 5 and n are as described herein, enantiomers and diastereomers thereof, and salts of these esters with weak acids, are...
|
|
|
5234947 |
Potassium channel activating compounds and methods of use thereof
A method for activating potassium channels and for treating hypertension, addiction, asthma, incontinence, and other conditions treatable by potassium channel activators, such as spasms and...
|
|
|
5234915 |
Biodegradable gel
A new gel-like composition of matter containing a complex carbohydrate with a high degree of carboxyl substitution cross-linked by an organic cross-linker has been developed. The cross-linkers have...
|
|
|
5227400 |
Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
A taxane derivative of the formula ##STR1## wherein ##STR2## Z is --OT 1 , T 1 is hydrogen, hydroxyl protecting group, or --COT 2 , T 2 is H, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 ...
|
|
|
5223532 |
Chromonyl/chromonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino derivatives
Non-peptidyl compounds characterized generally as chromonyl/chromonylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives are useful as renin inhibitors for treatment of...
|
|
|
5223534 |
Benzofuuranyl/benofuranylaklyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives
Non-peptidyl compounds characterized generally as benzofuranyl/benzofuranylalkyl-N-terminal cycloalkoxy-C-terminal amino hydroxy β-amino acid derivatives are useful as renin inhibitors for...
|
|
|
5214067 |
Fungicidal compositions and method
Novel fungicidal compositions comprising a pyranyl glycine ester compound and a β-lactone compound and a method for controlling mycotic infections is disclosed.
|
|
|
5192796 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST*** Fluoro taxols
This invention relates to a fluorinated taxol of formula I ##STR1## in which R 1 is benzoyl or t-butyloxycarbonyl; R 2 is acetoxy, hydrogen or hydroxy; and the wavy line indicates either the α-...
|
|
|
5157049 |
Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
The invention involves the treatment of cancer in humans by administering water soluble derivatives of taxol. The types of cancer so treatable are those sensitive to treatment with taxol.
|
|
|
5132106 |
Halogenated pyrimidine 3-oxide derivatives, their use for the treatment and prevention of hair loss and for stimulating its regrowth
The invention relates to compounds of formula: ##STR1## in which: R 1 and R 2 denote, independently of one another, a hydrogen atom or alternatively a carbamoyl group of formula: ##STR2## with R'...
|
|
|
5089492 |
Pharmaceuticals and dietetics containing acylamino acid derivatives
Acylamino carboxylic acid derivatives corresponding to the formula I ##STR1## in which the groups R 1 , R 2 , R 3 , Z 1 and Z 2 represent functional groups specified in the claims. The acylamino...
|
|
|
5077303 |
Oxirane phenyl esters and fungicides containing these
Esters of the general formula I ##STR1## where A is hydrogen, alkyl, cycloalkyl, cycloalkenyl, naphthyl, biphenyl, hetaryl or phenyl, these radicals being substituted or unsubstituted, and X is CH...
|
|
|
5066669 |
Benzofuran derivatives
A novel biphenyl derivative of the formula: ##STR1## wherein Ring A is a substituted or unsubstituted sulfur-containing or oxygen-containing heteromonocyclic ring; Ring B is a ring of the formula:...
|
|
|
5059623 |
Substituted cycloalkyl- and heterocyclyl-carboxanilides
A substituted cycloalkyl- or heterocyclyl-carboxanilide of the formula (I) ##STR1## in which X stands for an unsubstituted or an alkyl-substituted cycloalkyl or an unsubstituted or an...
|
|
|
5055485 |
Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides
A process of inactivating infectious viruses in a cell-containing or a protein-containing composition containing such viruses, comprising contacting such composition with an effective amount of at...
|